169 related articles for article (PubMed ID: 16698679)
1. Investigation of GM-CSF immune accessory effects in tumor-bearing mice by direct gene immunization.
Dou J; Hong X; Zhao F; Wang J; Chen J; Chen G
Immunol Invest; 2006; 35(2):227-37. PubMed ID: 16698679
[TBL] [Abstract][Full Text] [Related]
2. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
Guo C; Liu QG; Yang W; Yao YM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):188-92. PubMed ID: 18250039
[TBL] [Abstract][Full Text] [Related]
3. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
4. [Application of fusion gene mGM-CSF/hIL-2 to specific immunotherapy induced by hepatic tumor cell vaccine].
Yang W; Guo C; Liu QG
Ai Zheng; 2008 Feb; 27(2):149-54. PubMed ID: 18279611
[TBL] [Abstract][Full Text] [Related]
5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
7. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
Tang Q; Dou J; Zhao FS; Chu LL; Pan M; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):591-4. PubMed ID: 17618574
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.
Ali SA; McLean CS; Boursnell ME; Martin G; Holmes CL; Reeder S; Entwisle C; Blakeley DM; Shields JG; Todryk S; Vile R; Robins RA; Rees RC
Cancer Res; 2000 Mar; 60(6):1663-70. PubMed ID: 10749137
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor in a combination gene therapy strategy for head and neck cancer.
Day KV; Li D; Liu S; Guo M; O'Malley BW
Laryngoscope; 2001 May; 111(5):801-6. PubMed ID: 11368071
[TBL] [Abstract][Full Text] [Related]
11. [Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor].
Qing YL; Zhao JJ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):201-4. PubMed ID: 15099465
[TBL] [Abstract][Full Text] [Related]
12. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice.
Guo H; Chen G; Lu F; Chen H; Zheng H
Chin Med J (Engl); 2001 Mar; 114(3):317-20. PubMed ID: 11780322
[TBL] [Abstract][Full Text] [Related]
13. Induction of anti-tumor immunity by lyophilized myeloma cells secreting GM-CSF.
Wu S; Yuan D; Liu JN; Tan XY
Oncol Rep; 2007 Jan; 17(1):129-33. PubMed ID: 17143489
[TBL] [Abstract][Full Text] [Related]
14. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model.
Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N
Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795
[TBL] [Abstract][Full Text] [Related]
15. Induction of T-cell apoptosis in rats by genetically engineered glioma cells expressing granulocyte-macrophage colony-stimulating factor and B7.1.
Tseng SH; Chen Y; Chang CJ; Tai KF; Lin SM; Hwang LH
Clin Cancer Res; 2005 Feb; 11(4):1639-49. PubMed ID: 15746069
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
[TBL] [Abstract][Full Text] [Related]
17. [Enhanced inhibitory effect of MUC1 gene vaccine on breast cancer growth by GM-CSF].
Yuan SF; Li KZ; Wang L; Yan Z; Han W; Zhang YQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):737-40. PubMed ID: 15555449
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study on mouse interleukin-21 application in tumor gene therapy.
Dou J; Chen G; Wang J; Zhao F; Chen J; Fang X; Tang Q; Chu L
Cell Mol Immunol; 2004 Dec; 1(6):461-6. PubMed ID: 16293216
[TBL] [Abstract][Full Text] [Related]
19. Experimental study of specific immunotherapy induced by H22 autologous tumor as whole tumor cell vaccine.
Yang W; Guo C; Liu QG; Pan C
Biomed Pharmacother; 2009 Jul; 63(6):404-8. PubMed ID: 18849136
[TBL] [Abstract][Full Text] [Related]
20. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P
Prostate; 2005 Feb; 62(3):217-23. PubMed ID: 15389792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
